NEWS COMMENTARY

Amyris gets approval to sell its fermentation-derived Reb M product in Canada and Brazil

Published:
April 30, 2020
Coverage:
Accelerating Materials Innovation More...
Activities:
Markets More...
Average importance

Amyris initially launched its Reb M sweetener Purecane in December 2019 in the U.S., and the B2C product is currently sold through Purecane's e-commerce site as well as on Amazon. Following this regulatory approval, Amyris can expand to other countries like Canada and Brazil. Amyris produces its Reb M product by fermentation of cane sugar using an engineered S. cerevisiae production strain. The company previously announced an agreement with Raízen and is in the midst of building a commercial facility for Purecane in Brazil. While Amyris' commercialization through a B2C route provides the company a head start compared to DSM-Cargill's JV Avansya, widespread adoption of Purecane in the B2B sugar reduction market will be key to its success.

For the original news article, click here .


Further Reading

Global Bioenergies to launch its own range of cosmetic products

News Commentary | April 29, 2021

Global Bioenergies has been shifting its focus to high‑margin applications in recent years. The biotech startup now plans to produce and market a line of makeup products using its own bio‑based ingredient. It will initially produce 300,000 units and aims to have its commercial launch in the next six... Not part of subscription

DMC partners with Conagen for commercial production of L-alanine

News Commentary | May 21, 2021

This announcement follows the company's recent effort to demonstrate the large‑scale production of L‑alanine through 85 m3 fermentation at EW Biotech in Germany. In April 2021, the company also struck a deal with SCG to bring L‑alanine and other branched‑chain amino acids to the ASEAN market. ... Not part of subscription

Givaudan bets big on synthetic biology for specialty ingredients production

News Commentary | September 09, 2021

Givaudan and Manus Bio recently announced that they have achieved key scale‑up milestones in developing a food and beverage ingredient. While details on the target ingredient are scarce, Givaudan is looking to commercialize this ingredient by the end of this year. Interestingly, Givaudan also ... Not part of subscription